Anne-Marie Duliege
2016
In 2016, Anne-Marie Duliege earned a total compensation of $1.1M as Executive Vice President, Chief Medical Officer at Rigel Pharmaceuticals.
Compensation breakdown
Non-Equity Incentive Plan | $120,205 |
---|---|
Option Awards | $604,800 |
Salary | $358,197 |
Other | $62,795 |
Total | $1,145,997 |
Duliege received $604.8K in option awards, accounting for 53% of the total pay in 2016.
Duliege also received $120.2K in non-equity incentive plan, $358.2K in salary and $62.8K in other compensation.
Rankings
In 2016, Anne-Marie Duliege's compensation ranked 7,571st out of 14,075 executives tracked by ExecPay. In other words, Duliege earned more than 46.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,571 | 46th |
Manufacturing | 2,870 | 48th |
Chemicals And Allied Products | 945 | 50th |
Drugs | 731 | 53rd |
Pharmaceutical Preparations | 583 | 50th |
Duliege's colleagues
We found four more compensation records of executives who worked with Anne-Marie Duliege at Rigel Pharmaceuticals in 2016.